CISD1 and hepatocellular carcinoma: In parallel, HCC patients with high expression of CISD1 revealed worse survival with sorafenib treatment compared to the ones with low levels of CISD1, suggesting CISD1 expression and mitochondrial iron depletion were associated with sorafenib resistance (Supplementary Fig. 2D).